Search

Your search keyword '"Peptidyl-Dipeptidase A"' showing total 14,597 results

Search Constraints

Start Over You searched for: Descriptor "Peptidyl-Dipeptidase A" Remove constraint Descriptor: "Peptidyl-Dipeptidase A"
14,597 results on '"Peptidyl-Dipeptidase A"'

Search Results

51. Bidirectional relation between dipeptidyl peptidase 4 and angiotensin II type I receptor signaling.

53. Effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus (COVID-19) vaccination on male fertility.

54. A novel heat-stable angiotensin-converting enzyme zinc-binding motif inhibitory peptide identified from corn silk.

55. Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19.

56. ACE2 activation alleviates sepsis-induced cardiomyopathy by promoting MasR-Sirt1-mediated mitochondrial biogenesis.

57. Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2

58. Acute stress and cardiovascular health: is there an ACE gene connection?

59. SARS-CoV-2 infection downregulates myocardial ACE2 and potentiates cardiac inflammation in humans and hamsters

60. Elevated angiotensin-converting enzyme 2 (ACE2) expression in cats with hypertrophic cardiomyopathy

61. Evidence for Interplay Between the Renin–Angiotensin System and Toll-Like Receptor 4 Signaling Pathways in the Induction of Virus-Induced Acute Lung Injury

62. Identification, molecular docking, and kinetic studies of six novel angiotensin-I-converting enzyme (ACE) inhibitory peptides derived from Kenaf (Hibiscus cannabinus L.) seed

63. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs

64. The therapeutic potential of targeting ACE2 in COVID-19.

65. SARS、MERS和COVID-19感染所致肝损伤的临床特征及机制.

66. COVID-19 i djeca.

67. Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.

68. Energetics of Spike Protein Opening of SARS-CoV-1 and SARS-CoV-2 and Its Variants of Concern: Implications in Host Receptor Scanning and Transmission

69. Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry

70. Diffusion-Induced Ingress of Angiotensin-Converting Enzyme 2 into the Charge Conducting Path of a Pentacene Channel for Efficient Detection of SARS-CoV-2 in Saliva Samples

71. Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2

72. Mechanistic Insights into Angiotensin I-Converting Enzyme Inhibitory Tripeptides to Decipher the Chemical Basis of Their Activity

73. Respiratory Exposure to Copper Oxide Particles Causes Multiple Organ Injuries via Oxidative Stress in a Rat Model

74. Mechanisms of COVID-19 pathogenesis in diabetes

75. Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19

76. Angiotensin‐converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID‐19 severity in Iranian population

77. Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution

78. Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?

79. Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

80. Identification of Potential ACE2-Derived Peptide Mimetics in SARS-CoV-2 Omicron Variant Therapeutics using Computational Approaches

81. Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding In Vivo

82. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2

83. Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19?

84. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2

85. Covid‐19 and <scp>SARS‐CoV</scp> ‐2 infection in periodontology: A narrative review

86. Hemolytic anemia in COVID-19

87. Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry

88. Molecular imaging on ACE2‐dependent transocular infection of coronavirus

89. Atypical Unilateral SARS-CoV-2 Pneumonia in a Single Lung Re-Transplanted Patient: A Case Report

90. The impact of angiotensin converting enzyme insertion/deletion gene polymorphism on diabetic kidney disease: A debatable issue

91. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation

92. Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment

93. A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein

94. SARS-CoV-2 Induces Expression of Cytokine and MUC5AC/5B in Human Nasal Epithelial Cell through ACE 2 Receptor

95. Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives

96. Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells

97. Highly restricted SARS-CoV-2 receptor expression and resistance to infection by primary human monocytes and monocyte-derived macrophages

98. Probing structural basis for enhanced binding of SARS‐CoV‐2 P.1 variant spike protein with the human ACE2 receptor

99. Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson’s Disease

100. Physico‐chemical properties, antioxidant activity, and ACE inhibitory activity of protein hydrolysates from wild jujube seed

Catalog

Books, media, physical & digital resources